Using Proteins to Predict Active TB
Jacqueline Achkar, M.D., Biomarkers indicating the occurrence of active and contagious tuberculosis (TB) before someone develops symptoms would especially help people living with HIV (PLHIV).
New COVID-19 Vaccine Unit Opens at Montefiore and Albert Einstein College of Medicine
Barry S. Zingman, M.D., Montefiore’s goal is to ensure more than half of all trial participants are adults most affected by COVID-19, with a focus on people older than 65. Across the country, older individuals and communities of color have been disproportionately impacted by the pandemic.
NY doctor spearheading blood trial to help treat coronavirus patients
Liise-anne Pirofski, M.D., discusses the use of plasma from people who have recovered from COVID-19 to potentially prevent and treat the disease. Dr. Pirofski is chief of infectious diseases at Einstein and Montefiore.
Additional coverage includes: The
Lancet, CNN,
USA
Today, Nature,
The
Atlantic,
Wall Street Journal (subscription required),
Associated Press, NPR,
LA
Times, NBC
News, CBS
News
Back to Medical School During COVID-19
Joshua Nosanchuk, M.D., describes how, during the COVID-19 pandemic, Einstein medical students are contributing their ideas on how to accelerate courses—all while ensuring alignment with Einstein's mission and accreditation requirements. Dr. Nosanchuk is senior associate dean for medical education and professor of medicine and of microbiology & immunology. Read More.
A Blood Test May Show Which COVID-19 Patients Steroids Will Help—Or Harm
Marla Keller, M.D., Will Southern, M.D., M.S., and Shitij Arora, M.D., are co-authors on a study that finds a blood test can help physicians determine which hospitalized patients with COVID-19 can benefit from steroids. Dr. Keller is vice chair of research in the department of medicine; Dr. Southern is chief of hospital medicine; and Dr. Arora is associate professor of medicine and a hospitalist at Montefiore.
Additional coverage includes USA Today, LoHud, Fox News, U.S. News & World Report (via HealthDay), Daily Mail, LabPulse
Combating the COVID-19 Pandemic with Antibodies and a Patient Database
Along with many other Einstein and Montefiore scientists and physicians, infectious disease expert Liise-anne Pirofski, M.D., is working overtime to confront COVID-19, the disease caused by the new coronavirus.
How blood from coronavirus survivors might save lives
Dr. Liise-anne Pirofski Speaks to CNN About New COVID-19 Clinical Trial
Publications
JCI article on SARS-Cov-2 viral and antibody kinetics argues that convalescent plasma (CP) therapy functions differently early and late in COVID-19.
JCI article Kinetics of Viral Load and Antibody Response in Relation to COVID-19 Severity.
Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework
LA Times: Clinical Trial testing the healing powers of blood from COVID-19 Survivors
Trial for Potential Coronavirus Treatment is Underway at Montefiore and Einstein
Montefiore Health System and Albert Einstein College of Medicine has joined a clinical trial to evaluate the experimental drug remdesivir to treat people who are hospitalized with severe COVID-19 infection.
Antibiotic treatment for COVID-19 complications could fuel resistant bacteria
“We tend not to hold back on antibiotics in these patients,” Nori says, especially when that decision could mean life or death. “Is that a bad thing right now? I have trouble saying that it is.”
Covid-19 and Kidney Transplantation
To the Editor: Kidney-transplant recipients appear to be at particularly high risk for critical Covid-19 illness due to chronic immunosuppression and coexisting conditions.
news & multimedia archive
